Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001078782-17-000517
Filing Date
2017-04-19
Accepted
2017-04-19 13:56:17
Documents
70
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A AMENDED ANNUAL REPORT f10ka123116_10kz.htm 10-K/A 44713
2 EXHIBIT 31.1 SECTION 302 CERTIFICATION f10ka123116_ex31z1.htm EX-31.1 6064
3 EXHIBIT 32.1 SECTION 906 CERTIFICATION f10ka123116_ex32z1.htm EX-32.1 2798
  Complete submission text file 0001078782-17-000517.txt   2821016

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axim-20161231_cal.xml EX-101.CAL 4557
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axim-20161231_def.xml EX-101.DEF 39763
6 XBRL INSTANCE DOCUMENT axim-20161231.xml EX-101.INS 428415
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT axim-20161231_lab.xml EX-101.LAB 417899
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axim-20161231_pre.xml EX-101.PRE 230640
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axim-20161231.xsd EX-101.SCH 109043
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

EIN.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-54296 | Film No.: 17769593
SIC: 2834 Pharmaceutical Preparations